NR566 Midterm Exam - Advanced Pharmacology for Care of the Family Page 1
MIDTERM EXAM
NR566 / NR 566 (Latest 2026/2027)
Advanced Pharmacology for Care of the Family
Chamberlain University College of Nursing
Total Questions: 150 | Cognitive Mix: 20% Recall, 50% Application, 30% Analysis | Question Style: 75%
Scenario-based, 25% Direct Knowledge
Exam aligns with NR 566 Course Syllabus, AACN Essentials of Master's Education, and Family Nurse Practitioner
Pharmacology Competencies (2026/2027 Edition)
Section 1: Pharmacokinetics & Pharmacodynamics Across the Lifespan
Q1. A 4-week-old neonate is prescribed phenobarbital for seizures. The NP understands that, compared
with adults, neonatal hepatic drug metabolism is significantly reduced primarily because of which factor?
A. A. Decreased hepatic blood flow only
B. B. Immature CYP450 enzyme activity and decreased albumin binding capacity *[CORRECT]*
C. C. Increased first-pass metabolism and high glomerular filtration
D. D. Enhanced bile flow and mature conjugation pathways
Correct Answer: B
Rationale: Neonates have immature hepatic CYP450 enzyme systems (reaching adult values around 1 year) and lower
serum albumin with endogenous bilirubin competing for binding sites, leading to higher free-drug fractions. Options A, C,
and D are incorrect because neonatal hepatic blood flow is not the rate-limiting factor, first-pass metabolism is reduced
(not increased), and conjugation pathways are immature. Per NR566 lifespan pharmacokinetic principles, weight-based
dosing with careful therapeutic monitoring is mandatory in this population.
Q2. A 68-year-old female is started on diazepam for insomnia. Compared with a younger adult, she is at
higher risk for prolonged sedation primarily because of which pharmacokinetic change in older adults?
A. A. Increased total body water and decreased body fat
B. B. Decreased lean body mass and increased total body fat prolonging half-life of lipophilic drugs
*[CORRECT]*
C. C. Increased hepatic CYP3A4 activity accelerating metabolism
D. D. Increased glomerular filtration raising clearance of benzodiazepines
Correct Answer: B
Rationale: Aging reduces lean body mass and total body water while increasing adipose tissue, increasing the volume of
distribution (Vd) and half-life of lipophilic benzodiazepines such as diazepam. Beers Criteria explicitly recommends
avoiding diazepam in older adults due to this accumulation. Options A, C, and D describe changes opposite of what
occurs with aging, where hepatic CYP3A4 activity and GFR both tend to decline.
Chamberlain University | NR 566 Advanced Pharmacology | 2026/2027 Edition | Total Questions: 150
,NR566 Midterm Exam - Advanced Pharmacology for Care of the Family Page 2
Q3. Which statement correctly describes the first-pass effect and its clinical implication for an orally
administered drug?
A. A. It refers to drug metabolism occurring in gastric acid before absorption.
B. B. It is metabolism of a drug by the liver before reaching systemic circulation, reducing bioavailability
of oral doses. *[CORRECT]*
C. C. It is renal elimination of unchanged drug before hepatic metabolism.
D. D. It refers to drug binding to plasma proteins before distribution.
Correct Answer: B
Rationale: The first-pass effect describes hepatic (and intestinal) metabolism of an orally absorbed drug before it reaches
the systemic circulation, decreasing bioavailability and explaining why oral doses often exceed parenteral doses of the
same agent (e.g., propranolol, morphine). NR566 emphasizes this when choosing route of administration. A is incorrect
because gastric acid degradation is not the first-pass effect; C describes renal elimination; D describes distribution.
Q4. A drug has a half-life of 12 hours and follows first-order linear kinetics. Approximately how many
half-lives are required to reach steady-state plasma concentrations, and approximately when will steady
state be achieved?
A. A. 2 half-lives; ~24 hours
B. B. 3 half-lives; ~36 hours
C. C. 4-5 half-lives; ~48-60 hours *[CORRECT]*
D. D. 10 half-lives; ~120 hours
Correct Answer: C
Rationale: For drugs following first-order linear kinetics, steady state is achieved after approximately 4-5 half-lives
regardless of dose or dosing interval. With a 12-hour half-life, steady state is reached in roughly 48-60 hours. This NR566
principle underlies therapeutic drug monitoring timing such as waiting before drawing vancomycin or digoxin trough
levels. A and B underestimate; D overestimates the requirement.
Q5. A 72-year-old male with heart failure has a serum creatinine of 1.2 mg/dL (within 'normal' range).
Why is creatinine clearance (CrCl) a more accurate renal-function estimate in this patient than serum
creatinine alone?
A. A. Serum creatinine is unaffected by muscle mass.
B. B. Older adults have reduced muscle mass, so serum creatinine underestimates renal impairment; CrCl
accounts for age, weight, and sex. *[CORRECT]*
C. C. CrCl reflects hepatic metabolism more directly than serum creatinine.
D. D. Serum creatinine is a marker of glomerular filtration, not tubular secretion.
Correct Answer: B
Rationale: Older adults lose skeletal muscle mass; consequently serum creatinine may remain 'normal' despite
significantly reduced glomerular filtration. Estimating CrCl via Cockcroft-Gault incorporates age, weight, and sex,
providing a more accurate picture for renally-cleared drugs (e.g., gabapentin, digoxin, DOACs). NR566 stresses this for
safe geriatric prescribing. The other options either misstate physiology or describe hepatic rather than renal assessment.
Chamberlain University | NR 566 Advanced Pharmacology | 2026/2027 Edition | Total Questions: 150
,NR566 Midterm Exam - Advanced Pharmacology for Care of the Family Page 3
Q6. A patient taking warfarin is newly prescribed amiodarone. Within 2 weeks, the INR rises markedly
and bleeding occurs. What pharmacokinetic/pharmacodynamic mechanism best explains this interaction?
A. A. Amiodarone induces CYP2C9, increasing warfarin clearance.
B. B. Amiodarone inhibits CYP2C9 and CYP3A4, reducing warfarin metabolism and increasing INR.
*[CORRECT]*
C. C. Amiodarone increases warfarin protein binding, lowering free drug.
D. D. Amiodarone enhances renal excretion of warfarin metabolites.
Correct Answer: B
Rationale: Amiodarone is a potent inhibitor of CYP2C9 (the primary metabolic pathway for S-warfarin) and CYP3A4.
Inhibition reduces warfarin clearance, raises plasma concentration, and elevates INR with bleeding risk; the effect may
persist for weeks after amiodarone discontinuation due to its long half-life. NR566 emphasizes identification of
CYP-mediated interactions in patient-centered medication management. The other options either reverse the direction of
effect or describe mechanisms not applicable.
Q7. A drug administered intravenously has 100% bioavailability. The same drug given orally has an oral
bioavailability (F) of 0.60. If the desired systemic dose is 60 mg, what oral dose should be administered?
A. A. 36 mg
B. B. 60 mg
C. C. 100 mg *[CORRECT]*
D. D. 120 mg
Correct Answer: C
Rationale: Bioavailability (F) = (systemic dose) / (oral dose). To achieve 60 mg systemically with F = 0.60, the oral dose
= .60 = 100 mg. NR566 expects NPs to apply bioavailability corrections when switching between IV and oral dosing
(e.g., morphine, propranolol). Option A miscalculates by multiplying rather than dividing; B ignores bioavailability; D
doubles unnecessarily.
Q8. Which of the following is most accurate regarding protein binding and displacement interactions of
highly protein-bound drugs (e.g., warfarin, phenytoin)?
A. A. Displacement significantly raises free drug only when serum albumin is normal.
B. B. Displacement interactions are clinically relevant in hypoalbuminemia and at high protein-binding
percentages, transiently increasing free drug. *[CORRECT]*
C. C. Displacement interactions are always clinically significant regardless of organ function.
D. D. Displacement from albumin permanently increases the drug's volume of distribution.
Correct Answer: B
Rationale: For highly protein-bound drugs (>90%), displacement from albumin transiently increases free fraction, but the
clinical significance depends on hepatic/renal reserve, hypoalbuminemia, and the drug's narrow therapeutic index.
NR566 stresses that in hypoalbuminemia, free phenytoin levels may better reflect effect than total levels. The remaining
options overstate, understate, or mischaracterize the interaction.
Chamberlain University | NR 566 Advanced Pharmacology | 2026/2027 Edition | Total Questions: 150
, NR566 Midterm Exam - Advanced Pharmacology for Care of the Family Page 4
Q9. A breast-feeding mother requires treatment for mastitis and is prescribed cephalexin. Why is it
generally considered safe to continue breast-feeding with this medication?
A. A. Cephalexin concentrates in breast milk at therapeutic levels for the infant.
B. B. Only trace amounts of cephalexin pass into breast milk, and infant oral bioavailability is low with
minimal adverse effects. *[CORRECT]*
C. C. Cephalexin is fully metabolized by the mother before reaching milk.
D. D. Cephalexin blocks mammary duct absorption of all drugs.
Correct Answer: B
Rationale: Cephalexin is excreted in small amounts into breast milk; however, infant gut absorption is poor and clinically
relevant effects (such as diarrhea or candidiasis) are uncommon. NR566 incorporates lactation risk categories (L1-L5,
Hale's) and reinforces monitoring the infant for GI effects. A, C, and D overstate or misrepresent drug transfer.
Q10. A patient on a medication with a narrow therapeutic index requires monitoring of serum trough
levels. Which drug-level pairing is most appropriate?
A. A. Lisinopril - peak plasma level
B. B. Vancomycin - trough level before the 4th dose *[CORRECT]*
C. C. Metformin - random serum concentration
D. D. Amoxicillin - 1-hour post-dose peak
Correct Answer: B
Rationale: Vancomycin is a glycopeptide antibiotic with concentration-independent killing and a narrow therapeutic
window; trough levels drawn before the 4th dose (steady state) guide dosing to maintain efficacy (MIC) and minimize
nephrotoxicity. NR566 therapeutic drug monitoring content lists vancomycin, aminoglycosides, digoxin, lithium,
phenytoin, and warfarin as classic NTI drugs requiring level monitoring. The other agents do not require routine
drug-level monitoring.
Q11. A 6-month-old infant has approximately 75-80% total body water versus ~60% in adults. Which
pharmacokinetic consequence is most relevant when dosing water-soluble drugs (e.g., aminoglycosides)?
A. A. Lower mg/kg dose required than adults
B. B. Larger mg/kg dose required to achieve therapeutic serum concentrations *[CORRECT]*
C. C. No dose adjustment is needed due to mature renal function
D. D. Volume of distribution is decreased
Correct Answer: B
Rationale: Pediatric patients, especially infants, have a larger percentage of total body water and extracellular fluid,
increasing the Vd of water-soluble drugs such as gentamicin; thus mg/kg dosing is higher than adults to achieve
therapeutic concentrations. NR566 lifespan dosing content emphasizes weight-based dosing with monitoring for pediatric
aminoglycosides. A and D reverse the relationship; C incorrectly assumes mature renal function.
Chamberlain University | NR 566 Advanced Pharmacology | 2026/2027 Edition | Total Questions: 150
MIDTERM EXAM
NR566 / NR 566 (Latest 2026/2027)
Advanced Pharmacology for Care of the Family
Chamberlain University College of Nursing
Total Questions: 150 | Cognitive Mix: 20% Recall, 50% Application, 30% Analysis | Question Style: 75%
Scenario-based, 25% Direct Knowledge
Exam aligns with NR 566 Course Syllabus, AACN Essentials of Master's Education, and Family Nurse Practitioner
Pharmacology Competencies (2026/2027 Edition)
Section 1: Pharmacokinetics & Pharmacodynamics Across the Lifespan
Q1. A 4-week-old neonate is prescribed phenobarbital for seizures. The NP understands that, compared
with adults, neonatal hepatic drug metabolism is significantly reduced primarily because of which factor?
A. A. Decreased hepatic blood flow only
B. B. Immature CYP450 enzyme activity and decreased albumin binding capacity *[CORRECT]*
C. C. Increased first-pass metabolism and high glomerular filtration
D. D. Enhanced bile flow and mature conjugation pathways
Correct Answer: B
Rationale: Neonates have immature hepatic CYP450 enzyme systems (reaching adult values around 1 year) and lower
serum albumin with endogenous bilirubin competing for binding sites, leading to higher free-drug fractions. Options A, C,
and D are incorrect because neonatal hepatic blood flow is not the rate-limiting factor, first-pass metabolism is reduced
(not increased), and conjugation pathways are immature. Per NR566 lifespan pharmacokinetic principles, weight-based
dosing with careful therapeutic monitoring is mandatory in this population.
Q2. A 68-year-old female is started on diazepam for insomnia. Compared with a younger adult, she is at
higher risk for prolonged sedation primarily because of which pharmacokinetic change in older adults?
A. A. Increased total body water and decreased body fat
B. B. Decreased lean body mass and increased total body fat prolonging half-life of lipophilic drugs
*[CORRECT]*
C. C. Increased hepatic CYP3A4 activity accelerating metabolism
D. D. Increased glomerular filtration raising clearance of benzodiazepines
Correct Answer: B
Rationale: Aging reduces lean body mass and total body water while increasing adipose tissue, increasing the volume of
distribution (Vd) and half-life of lipophilic benzodiazepines such as diazepam. Beers Criteria explicitly recommends
avoiding diazepam in older adults due to this accumulation. Options A, C, and D describe changes opposite of what
occurs with aging, where hepatic CYP3A4 activity and GFR both tend to decline.
Chamberlain University | NR 566 Advanced Pharmacology | 2026/2027 Edition | Total Questions: 150
,NR566 Midterm Exam - Advanced Pharmacology for Care of the Family Page 2
Q3. Which statement correctly describes the first-pass effect and its clinical implication for an orally
administered drug?
A. A. It refers to drug metabolism occurring in gastric acid before absorption.
B. B. It is metabolism of a drug by the liver before reaching systemic circulation, reducing bioavailability
of oral doses. *[CORRECT]*
C. C. It is renal elimination of unchanged drug before hepatic metabolism.
D. D. It refers to drug binding to plasma proteins before distribution.
Correct Answer: B
Rationale: The first-pass effect describes hepatic (and intestinal) metabolism of an orally absorbed drug before it reaches
the systemic circulation, decreasing bioavailability and explaining why oral doses often exceed parenteral doses of the
same agent (e.g., propranolol, morphine). NR566 emphasizes this when choosing route of administration. A is incorrect
because gastric acid degradation is not the first-pass effect; C describes renal elimination; D describes distribution.
Q4. A drug has a half-life of 12 hours and follows first-order linear kinetics. Approximately how many
half-lives are required to reach steady-state plasma concentrations, and approximately when will steady
state be achieved?
A. A. 2 half-lives; ~24 hours
B. B. 3 half-lives; ~36 hours
C. C. 4-5 half-lives; ~48-60 hours *[CORRECT]*
D. D. 10 half-lives; ~120 hours
Correct Answer: C
Rationale: For drugs following first-order linear kinetics, steady state is achieved after approximately 4-5 half-lives
regardless of dose or dosing interval. With a 12-hour half-life, steady state is reached in roughly 48-60 hours. This NR566
principle underlies therapeutic drug monitoring timing such as waiting before drawing vancomycin or digoxin trough
levels. A and B underestimate; D overestimates the requirement.
Q5. A 72-year-old male with heart failure has a serum creatinine of 1.2 mg/dL (within 'normal' range).
Why is creatinine clearance (CrCl) a more accurate renal-function estimate in this patient than serum
creatinine alone?
A. A. Serum creatinine is unaffected by muscle mass.
B. B. Older adults have reduced muscle mass, so serum creatinine underestimates renal impairment; CrCl
accounts for age, weight, and sex. *[CORRECT]*
C. C. CrCl reflects hepatic metabolism more directly than serum creatinine.
D. D. Serum creatinine is a marker of glomerular filtration, not tubular secretion.
Correct Answer: B
Rationale: Older adults lose skeletal muscle mass; consequently serum creatinine may remain 'normal' despite
significantly reduced glomerular filtration. Estimating CrCl via Cockcroft-Gault incorporates age, weight, and sex,
providing a more accurate picture for renally-cleared drugs (e.g., gabapentin, digoxin, DOACs). NR566 stresses this for
safe geriatric prescribing. The other options either misstate physiology or describe hepatic rather than renal assessment.
Chamberlain University | NR 566 Advanced Pharmacology | 2026/2027 Edition | Total Questions: 150
,NR566 Midterm Exam - Advanced Pharmacology for Care of the Family Page 3
Q6. A patient taking warfarin is newly prescribed amiodarone. Within 2 weeks, the INR rises markedly
and bleeding occurs. What pharmacokinetic/pharmacodynamic mechanism best explains this interaction?
A. A. Amiodarone induces CYP2C9, increasing warfarin clearance.
B. B. Amiodarone inhibits CYP2C9 and CYP3A4, reducing warfarin metabolism and increasing INR.
*[CORRECT]*
C. C. Amiodarone increases warfarin protein binding, lowering free drug.
D. D. Amiodarone enhances renal excretion of warfarin metabolites.
Correct Answer: B
Rationale: Amiodarone is a potent inhibitor of CYP2C9 (the primary metabolic pathway for S-warfarin) and CYP3A4.
Inhibition reduces warfarin clearance, raises plasma concentration, and elevates INR with bleeding risk; the effect may
persist for weeks after amiodarone discontinuation due to its long half-life. NR566 emphasizes identification of
CYP-mediated interactions in patient-centered medication management. The other options either reverse the direction of
effect or describe mechanisms not applicable.
Q7. A drug administered intravenously has 100% bioavailability. The same drug given orally has an oral
bioavailability (F) of 0.60. If the desired systemic dose is 60 mg, what oral dose should be administered?
A. A. 36 mg
B. B. 60 mg
C. C. 100 mg *[CORRECT]*
D. D. 120 mg
Correct Answer: C
Rationale: Bioavailability (F) = (systemic dose) / (oral dose). To achieve 60 mg systemically with F = 0.60, the oral dose
= .60 = 100 mg. NR566 expects NPs to apply bioavailability corrections when switching between IV and oral dosing
(e.g., morphine, propranolol). Option A miscalculates by multiplying rather than dividing; B ignores bioavailability; D
doubles unnecessarily.
Q8. Which of the following is most accurate regarding protein binding and displacement interactions of
highly protein-bound drugs (e.g., warfarin, phenytoin)?
A. A. Displacement significantly raises free drug only when serum albumin is normal.
B. B. Displacement interactions are clinically relevant in hypoalbuminemia and at high protein-binding
percentages, transiently increasing free drug. *[CORRECT]*
C. C. Displacement interactions are always clinically significant regardless of organ function.
D. D. Displacement from albumin permanently increases the drug's volume of distribution.
Correct Answer: B
Rationale: For highly protein-bound drugs (>90%), displacement from albumin transiently increases free fraction, but the
clinical significance depends on hepatic/renal reserve, hypoalbuminemia, and the drug's narrow therapeutic index.
NR566 stresses that in hypoalbuminemia, free phenytoin levels may better reflect effect than total levels. The remaining
options overstate, understate, or mischaracterize the interaction.
Chamberlain University | NR 566 Advanced Pharmacology | 2026/2027 Edition | Total Questions: 150
, NR566 Midterm Exam - Advanced Pharmacology for Care of the Family Page 4
Q9. A breast-feeding mother requires treatment for mastitis and is prescribed cephalexin. Why is it
generally considered safe to continue breast-feeding with this medication?
A. A. Cephalexin concentrates in breast milk at therapeutic levels for the infant.
B. B. Only trace amounts of cephalexin pass into breast milk, and infant oral bioavailability is low with
minimal adverse effects. *[CORRECT]*
C. C. Cephalexin is fully metabolized by the mother before reaching milk.
D. D. Cephalexin blocks mammary duct absorption of all drugs.
Correct Answer: B
Rationale: Cephalexin is excreted in small amounts into breast milk; however, infant gut absorption is poor and clinically
relevant effects (such as diarrhea or candidiasis) are uncommon. NR566 incorporates lactation risk categories (L1-L5,
Hale's) and reinforces monitoring the infant for GI effects. A, C, and D overstate or misrepresent drug transfer.
Q10. A patient on a medication with a narrow therapeutic index requires monitoring of serum trough
levels. Which drug-level pairing is most appropriate?
A. A. Lisinopril - peak plasma level
B. B. Vancomycin - trough level before the 4th dose *[CORRECT]*
C. C. Metformin - random serum concentration
D. D. Amoxicillin - 1-hour post-dose peak
Correct Answer: B
Rationale: Vancomycin is a glycopeptide antibiotic with concentration-independent killing and a narrow therapeutic
window; trough levels drawn before the 4th dose (steady state) guide dosing to maintain efficacy (MIC) and minimize
nephrotoxicity. NR566 therapeutic drug monitoring content lists vancomycin, aminoglycosides, digoxin, lithium,
phenytoin, and warfarin as classic NTI drugs requiring level monitoring. The other agents do not require routine
drug-level monitoring.
Q11. A 6-month-old infant has approximately 75-80% total body water versus ~60% in adults. Which
pharmacokinetic consequence is most relevant when dosing water-soluble drugs (e.g., aminoglycosides)?
A. A. Lower mg/kg dose required than adults
B. B. Larger mg/kg dose required to achieve therapeutic serum concentrations *[CORRECT]*
C. C. No dose adjustment is needed due to mature renal function
D. D. Volume of distribution is decreased
Correct Answer: B
Rationale: Pediatric patients, especially infants, have a larger percentage of total body water and extracellular fluid,
increasing the Vd of water-soluble drugs such as gentamicin; thus mg/kg dosing is higher than adults to achieve
therapeutic concentrations. NR566 lifespan dosing content emphasizes weight-based dosing with monitoring for pediatric
aminoglycosides. A and D reverse the relationship; C incorrectly assumes mature renal function.
Chamberlain University | NR 566 Advanced Pharmacology | 2026/2027 Edition | Total Questions: 150
